Bioscience Co., Ltd. (600201.SH) reported its semi-annual performance, with a net profit attributable to shareholders of 104 million yuan, a year-on-year increase of 72.28%.

Zhitong Finance APP News, Bio-Pharmaceutical Co., Ltd. (600201.SH) disclosed its semi-annual report for 2026. During the reporting period, the company achieved revenue of 756 million yuan, a year-on-year increase of 22.09%; net profit attributable to shareholders of the listed company was 104 million yuan, a year-on-year increase of 72.28%; net profit excluding non-recurring gains and losses was 89.69 million yuan, a year-on-year increase of 178.61%; basic earnings per share were 0.10 yuan.